Ellis

June 24, 2020 | New Jersey Law Journal

New Jersey has a significant and rare opportunity to be the first state in the tristate area to enact a strong, robust legal cannabis industry that addresses the harm caused by the criminalization of a medicinal plant.

By Jessica F. Gonazlez and Brian J. Ellis

8 minute read

January 24, 2020 | Insurance Coverage Law Center

California Supreme Court Holds that Requirement of Prejudice for Late Notice Defense is a Fundamental Public Policy of the State for Choice of Law Analysis. California's…

By Michael S. Levine & Latosha M. Ellis

9 minute read

January 23, 2020 | Insurance Coverage Law Center

Courts in 2019 made several groundbreaking decisions on long-tail claims, late notice, and malicious prosecutions. Read about them here!

By Michael S. Levine & Latosha M. Ellis

7 minute read

January 22, 2020 | Insurance Coverage Law Center

No matter the type of insurance, policy exclusions are always of critical importance. These 2019 decisions will help us interpret policies in the future.

By Michael S. Levine & Latosha M. Ellis

4 minute read

January 21, 2020 | Insurance Coverage Law Center

2019 saw a flurry of decisions under directors and officers (D&O) insurance policies, including a bizarre and self-prompted change of heart by the…

By Michael S. Levine & Latosha M. Ellis

7 minute read

January 17, 2020 | Insurance Coverage Law Center

Featuring several 2019 social engineering insurance coverage decisions that will undoubtedly shape the coverage landscape for years to come.

By Michael S. Levine & Latosha M. Ellis

5 minute read

November 27, 2019 | Delaware Business Court Insider

Shareholder inspection of books and records pursuant to Section 220 of the Delaware General Corporation Law is a routine procedure for Delaware practitioners, and represents an important tool for shareholders when it comes to their involvement in corporate governance.

By Ellis E. Herington

7 minute read

June 28, 2019 | Daily Business Review

A University of Miami pilot program protects drug users by allowing them to exchange used syringes for clean ones in order to avoid the transmission of HIV, hepatitis C and other blood-borne diseases.

By Ellis Rua

4 minute read

June 25, 2019 | The Legal Intelligencer

While the president and Congress gave hemp the go-ahead, it is now on the regulators to take the next step. The FDA has authority to regulate cannabis-derived compounds, including CBD, under the Federal Food, Drug, and Cosmetic Act. So far, though, the FDA has not done much regulating in regards to CBD.

By Joshua Horn and Ellis W. Martin

7 minute read

June 12, 2019 | Texas Lawyer

Senate Bill 421 was shot down in the Texas Legislature.

By Justin Hodge, John Appel and Luke Ellis

6 minute read